Article
Efficacy and safety of simeprevir in combination with peginterferon and ribavirin for patients with hepatitis C genotype 1 infection: a meta-analysis of randomized trials.
Revista espanola de enfermedades digestivas - 1 Oct 2015
Cui Xianghua, Kong Yuanyuan, Jia Jidong
Abstract excerpt
BACKGROUND AND AIM: A simeprevir (SMV)-based regimen has shown promising results in treating chronic hepatitis C virus (HCV) infection. This meta-analysis aimed to assess the efficacy and safety of simeprevir for treating HCV genotype 1 infection. METHODS: MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials were searched, along with the reference lists of retrieved articles. The meta-analysis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.